Bristol-Myers Squibb
BMY
#78
Rank
$141.06 B
Marketcap
$66.64
Share price
0.17%
Change (1 day)
-6.20%
Change (1 year)

P/E ratio for Bristol-Myers Squibb (BMY)

P/E ratio as of March 2023 (TTM): 21.4

According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.3921. At the end of 2021 the company had a P/E ratio of 19.7.

P/E ratio history for Bristol-Myers Squibb from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202119.7-226.77%
2020-15.5-153.28%
201929.169.66%
201817.2
201621.9-69.14%
201570.945.37%
201448.843.19%
201334.121.27%
201228.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
21.0-1.88%๐Ÿ‡บ๐Ÿ‡ธ USA
8.46-60.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
7.64-64.31%๐Ÿ‡บ๐Ÿ‡ธ USA
23.2 8.44%๐Ÿ‡บ๐Ÿ‡ธ USA
49.7 132.35%๐Ÿ‡บ๐Ÿ‡ธ USA
18.5-13.49%๐Ÿ‡บ๐Ÿ‡ธ USA
14.5-32.23%๐Ÿ‡ซ๐Ÿ‡ท France
12.6-40.95%๐Ÿ‡บ๐Ÿ‡ธ USA
17.6-17.76%๐Ÿ‡บ๐Ÿ‡ธ USA
100 367.89%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.